Specialty Injectable Drugs Set to Become $85 Billion Global Market
Growth Dependent on Four Core Therapeutic Segments which account for 75% of the Market according To Greystone Research Associates
Oncology drugs represent the most active pharmaceutical segment in terms of drug candidate development activity. As oncology drugs continue to evolve in sophistication, the number of antibodies and other targeted treatments for treating various forms of cancer that reach the market as injectables will increase, while the majority of the remainder will migrate from intravenous delivery to injectable dosage forms within 36 months of market launch. These drugs will offset the revenue erosion expected to occur due to pricing pressures from biosimilars in the four core specialty injectables segments, and drive total specialty injectable drug growth higher.
Detailed analysis of specialty injectable drugs, therapeutic sectors, and participants is included in a new and comprehensive report. Injectable Drug Delivery to 2020, researched and written by Greystone Research, analyzes specialty injectables across eleven major therapeutic drug segments, assesses market risks and opportunities, examines regulatory and market factors and profiles market participants.
More information is available at http://www.greystoneassociates.org/Injectable_Delivery.htm
Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
Press releases you might also be interested in
Weitere Informationen zum Thema "Medical Technology":
Zendesk stellt Guide Enterprise vor
Mit Guide Enterprise will Zendesk Wissenslücken im Kundenservice schließen. Die KI-gestützte Self-Service-Lösung ist für den Einsatz in Großunternehmen konzipiert.Weiterlesen